focus -WSS

focus

author：focus 2025-09-28 22:52:47 - browse：24812

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Medicare Advantage insurers face 0.2% cut to 2025 payments

WSS

Merck, Johnson & Johnson CEOs will testify on high drug prices

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Humana’s losses in Medicare Advantage tank its stock

White House pharmacy plagued with problems, investigation finds

Health Care Service Corp to buy Cigna Medicare Advantage plans

Venture capital firm's plans to take over Akron hospital face hurdles

explore

focus

explore

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Peter Hotez and the public health issue of online harassment

Medicare Advantage insurers face 0.2% cut to 2025 payments

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Humana’s losses in Medicare Advantage tank its stock

Jerome Adams on the need for new antivirals for Covid

Bernie Sanders is gearing up to subpoena pharma CEOs

Continuity nursing helped my family in our darkest PICU moments

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Wikipedia

Medicare Advantage insurers face 0.2% cut to 2025 payments

Venture capital firm's plans to take over Akron hospital face hurdles

Humana’s losses in Medicare Advantage tank its stock

Health Care Service Corp to buy Cigna Medicare Advantage plans

Biogen walks away from Aduhelm, years after polarizing approval

North Korean leader's powerful sister says warplanes repelled US spy plane

hotspot

focus

hotspot

focus